Yin Weidong, the CEO of China's Sinovac Biotech Ltd has said that about 90% of the firm's employees and their families have taken an experimental coronavirus vaccine developed by the firm on a voluntary basis. The vaccine has been developed under the country's emergency use program. Sinovac's CoronaVac is in Phase 3 clinical trials.